Clinical Trial

Study of Radiotherapy Combined With Platinum, Adebrelimab and Bevazumab in the Treatment of TNBC-BM.

Name: Study of Radiotherapy Combined With Platinum, Adebrelimab and Bevazumab in the Treatment of TNBC-BM. — clinical trial record (NCT07638852)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: ABC-R

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This is an open-label, prospective, single-arm, multicenter phase II clinical trial. The aim is to explore the efficacy and safety of radiotherapy combined with cisplatin/carboplatin, adebrelimab, and bevacizumab in patients with triple-negative breast cancer and brain metastases.

Trial Details

NCT Number	NCT07638852
Lead Sponsor	Fudan University
Conditions	TNBC, Triple Negative Breast Cancer, Brain Metastasases
Enrollment	58 participants
Start Date	2026-02-23
Primary Completion	2028-06-30 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-10